Related Experiment Video
Updated: Jul 5, 2025

14:16
Fluorescence detection methods for microfluidic droplet platforms
Published on: December 10, 2011
22.2K
Droplet-Based Preparation of ZnO-nanostructure Array for Microfluidic Fluorescence Biodetection
Zhenlong Wang1, Sai-Xi Yu2, Xuan Shao1
1Engineering Research Center for Nanophotonics and Advanced Instrument, School of Physics and Electronic Science, East China Normal University, Shanghai 200062, China.
ACS Applied Materials & Interfaces
|January 25, 2024
Summary
This study introduces a novel droplet microfluidic chip for the patterned growth of zinc oxide (ZnO) nanostructures. This platform enables highly sensitive, multiplexed detection of cancer biomarkers, improving early cancer diagnosis.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Analytical Chemistry
Background:
- Nanostructure-enhanced biodetection is crucial for early cancer diagnosis and treatment.
- Zinc oxide (ZnO) nanostructures offer excellent biocompatibility and fluorescence enhancement for sensitive cancer biomarker detection.
- Existing fluorescence detection methods require optimization for high sensitivity, multiplexing, and user-friendliness.
Purpose of the Study:
- To develop a simple droplet microfluidic chip for in situ, patterned growth of ZnO nanostructures.
- To investigate the controlled growth of ZnO nanostructures within static droplets.
- To demonstrate the application of patterned ZnO nanostructures in multiplexed fluorescence immunoassay for cancer biomarkers.
Main Methods:
- Fabrication of a simple droplet microfluidic chip for static droplet arrays.
- In situ growth of ZnO nanostructures by controlling growth time and replenishment intervals.
- Application of patterned ZnO nanostructures for fluorescence immunoassay of cancer biomarkers (human α-fetoprotein and carcinoembryonic antigen).
Main Results:
- Successful patterned growth of ZnO nanostructures with varied diameters in static droplets.
- Achieved low limits of detection for cancer biomarkers: 138 fg/mL for human α-fetoprotein and 218 fg/mL for carcinoembryonic antigen.
- Demonstrated a wide dynamic range of 8 orders for biomarker detection.
Conclusions:
- The developed droplet microfluidic device offers a novel approach for patterned ZnO nanostructure growth.
- This platform provides guidance for designing multiple fluorescence amplification systems for biosensing.
- The multifunctional microfluidic devices show potential as efficient tools for fluorescence-based cancer diagnostic assays.

